Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05172960 · ClinicalTrials.gov registry record · NA
ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve
A NA study of Aortic Stenosis, Severe, sponsored by Edwards Lifesciences.
- Active
- Registry status
- NA
- Development phase
- 915
- Enrollment target
- 20
- Study locations
NCT05172960 is a NA study of Aortic Stenosis, Severe that is active but no longer recruiting, run by Edwards Lifesciences. The registered enrollment target is 915 participants. The trial reports 20 study locations across 8 states.
The verdict
NCT05172960, a NA study of Aortic Stenosis, Severe, is active but no longer recruiting, sponsored by Edwards Lifesciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 915 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4 Transcatheter Heart Valve (THV) in subjects with symptomatic, severe, calcific aortic stenosis (AS).
Conditions Studied
Interventions
- DEVICE SAPIEN X4 THV
Study Locations (20)
California
- Scripps Memorial Hospital La Jolla - La Jolla
- Kaiser Los Angeles - Los Angeles
- Cedars-Sinai Medical Center - Los Angeles
- Hoag Memorial Hospital Presbyterian - Newport Beach
- UC Davis Medical Center Sacramento - Sacramento
- Bay Area Structural Heart at Sutter Health - San Francisco
- Kaiser San Francisco Medical Center - San Francisco
- Stanford University - Stanford
Illinois
- Rush University Medical Center Chicago - Chicago
- Alexian Brothers Hospital Network - Elk Grove Village
- NorthShore University HealthSystem Research Institute Evanston - Evanston
- Northwestern University Chicago - Evanston
- Silver Cross Hospital - New Lenox
Georgia
- Piedmont Heart Institute - Atlanta
- Emory University Atlanta - Atlanta
Colorado
- UC Health Northern Colorado (Medical Center of the Rockies) - Loveland
Connecticut
- Hartford Hospital - Hartford
Florida
- Naples Community Hospital Healthcare System - North Naples
Indiana
- St. Vincent Medical Group, Inc./ St. Vincent Heart Center of Indiana, LLC - Carmel
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 915 participants |
| Start Date | 2022-06-20 |
| Est. Completion | 2034-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05172960
The ClinicalTrials.gov registry entry for NCT05172960 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 915 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aortic Stenosis, Severe appearing as the primary indexed condition, and to 1 intervention - of which SAPIEN X4 THV is the first listed.
NCT05172960 reports 20 study locations spanning 8 distinct geographic areas - top geographies include California, Illinois, Georgia.
Frequently Asked Questions
What is clinical trial NCT05172960 about?
NCT05172960 is a clinical study titled "ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve". The objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4 Transcatheter Heart Valve (THV) in subjects with symptomatic, severe, calcific aortic stenosis (AS).
What is the current status of trial NCT05172960?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 915 participants. The study started on 2022-06-20. Estimated completion is 2034-12.
What conditions does trial NCT05172960 study?
This clinical trial studies the following conditions: Aortic Stenosis, Severe.
What interventions are being tested in trial NCT05172960?
The interventions under investigation include: SAPIEN X4 THV (DEVICE).
Who is sponsoring clinical trial NCT05172960?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05172960 being conducted?
This trial has 20 study locations across California, Colorado, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Stenosis, Severe
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.